J Claude Hemphill, Patrick Lyden. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Age FactorsAgedAging/physiologyBrain Ischemia/physiopathologyBrain Ischemia/therapyCerebral Hemorrhage/chemically inducedCerebral Hemorrhage/mortalityCohort StudiesContraindicationsFemaleFibrinolytic Agents/adverse effectsHumansMalePatient Selection/ethicsRetrospective StudiesRisk AssessmentStroke/physiopathologyStroke/therapySurvival Rate/trendsThrombolytic Therapy/adverse effectsTissue Plasminogen Activator/adverse effectsTreatment OutcomeWithholding Treatment/ethics
Substances： See more » Fibrinolytic AgentsTissue Plasminogen Activator
Year: 2005 PMID： 16344508 DOI： 10.1212/01.wnl.0000192631.39824.93
Source DB: PubMed Journal: Neurology ISSN： 0028-3878 Impact factor: 9.910